Impact of the COVID-19 pandemic on healthcare resource utilization across selected disease areas in the USA - Supplementary materials.docx

Supplementary Table 1. Pharmaceutical disease cohorts' characteristics Supplementary Table 2. Oncology disease cohorts' characteristics Supplementary Table 3. Disease areas and ICD-10 clinical modification diagnosis codes. Supplementary Table 4. Total pre-pandemic and pandemic outpatient visits and the percentage change in outpatient visits for each disease area. Supplementary Table 5. Total pre-pandemic and pandemic inpatient visits and the percentage change in inpatient visits for each disease area. Supplementary Table 6. Total pre-pandemic and pandemic ED visits and the percentage change in ED visits for each disease area.